A group of Indigenous elders and chiefs is suing to void all forestry permits on a vast territory in northern Quebec, ...
Canada’s public drug plans should not pay for a new medication that slows cognitive decline in patients with Alzheimer’s disease because it’s not clear the expensive therapy provides clinically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results